Page last updated: 2024-10-24

bupivacaine and Idiopathic Pulmonary Fibrosis

bupivacaine has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Idiopathic Pulmonary Fibrosis: A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, AJ1
Marciniak, D1

Other Studies

1 other study available for bupivacaine and Idiopathic Pulmonary Fibrosis

ArticleYear
Bilateral Serratus Anterior Plane (SAP) Catheters: ANovel Approach to Promote Postoperative Recovery After Bilateral Sequential Lung Transplantation.
    Journal of cardiothoracic and vascular anesthesia, 2019, Volume: 33, Issue:5

    Topics: Bupivacaine; Catheters, Indwelling; Humans; Idiopathic Pulmonary Fibrosis; Intermediate Back Muscles

2019